10-Q Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001739104-18-000005`
Period End Date	20180930
Filing Date	20181108
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	elan-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 52 Cash Flow Statement 56 Stockholders Equity 25 Comprehensive Income 12

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$9.80M	USD	Point-in-time
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.80M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$834.10M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$894.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$300.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$323.40M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$343.60M	USD	Point-in-time
Accounts receivable, net of allowances of $8.8 (2018) and $9.8 (2017)	`AccountsReceivableNetCurrent`	$606.10M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	365.62M	shares	Point-in-time
Accounts receivable, net of allowances of $8.8 (2018) and $9.8 (2017)	`AccountsReceivableNetCurrent`	$567.40M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	365.62M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$34.50M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	365.62M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	365.62M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$30.80M	USD	Point-in-time
Inventories (Note 7)	`InventoryNet`	$1.06B	USD	Point-in-time
Inventories (Note 7)	`InventoryNet`	$1.01B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$136.10M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$123.20M	USD	Point-in-time
Restricted cash (Note 14)	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash (Note 14)	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash (Note 14)	`RestrictedCashCurrent`	$634.90M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.70B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12B	USD	Point-in-time
Investments (Note 9)	`Investments`	$12.30M	USD	Point-in-time
Investments (Note 9)	`Investments`	$14.90M	USD	Point-in-time
Goodwill	`Goodwill`	$2.97B	USD	Point-in-time
Goodwill	`Goodwill`	$2.97B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.51B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.67B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$100.00M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$242.00M	USD	Point-in-time
Property and equipment, net of accumulated depreciation $894.5 (2018) and $834.1 (2017)	`PropertyPlantAndEquipmentNet`	$920.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation $894.5 (2018) and $834.1 (2017)	`PropertyPlantAndEquipmentNet`	$909.30M	USD	Point-in-time
Total assets	`Assets`	$8.94B	USD	Point-in-time
Total assets	`Assets`	$9.21B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$203.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$202.70M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$89.30M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$81.30M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$165.50M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$147.90M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$184.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$178.60M	USD	Point-in-time
Payable to Lilly (Note 14)	`DueToRelatedPartiesNoncurrent`	$634.90M	USD	Point-in-time
Payable to Lilly (Note 14)	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$643.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25B	USD	Point-in-time
Long-term debt (Note 8)	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long-term debt (Note 8)	`LongTermDebtNoncurrent`	$2.48B	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$139.00M	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$136.00M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$251.90M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$125.00M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$89.50M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$126.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.16B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.07B	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Net parent company investment	`NetParentCompanyInvestment`	$8.04B	USD	Point-in-time
Net parent company investment	`NetParentCompanyInvestment`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized 365,625,000 shares issued and outstanding as of September 30, 2018	`CommonStockValue`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized 365,625,000 shares issued and outstanding as of September 30, 2018	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.35B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-256.60M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-210.30M	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.02B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.96B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.78B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.14B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.94B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$9.21B	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.27B	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$697.10M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$761.10M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.13B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.16B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.09B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$369.80M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$376.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$185.50M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$61.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$189.70M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$58.90M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$179.00M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$194.70M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$583.00M	USD	3 Qtrs
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$550.10M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$147.30M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$161.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$51.60M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$48.70M	USD	1 Quarter
Asset impairments, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$23.70M	USD	1 Quarter
Asset impairments, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$12.40M	USD	1 Quarter
Asset impairments, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$189.30M	USD	3 Qtrs
Asset impairments, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$82.80M	USD	3 Qtrs
Othernet, (income) expense	`NonoperatingIncomeExpense`	-	USD	3 Qtrs
Othernet, (income) expense	`NonoperatingIncomeExpense`	$-13.50M	USD	1 Quarter
Othernet, (income) expense	`NonoperatingIncomeExpense`	$1.90M	USD	1 Quarter
Othernet, (income) expense	`NonoperatingIncomeExpense`	$-24.20M	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$2.15B	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$2.21B	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$706.20M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$682.30M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.10M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-77.20M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$116.30M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$78.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$46.20M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$11.60M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$72.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$18.60M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-20.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$0.16	USD	1 Quarter
Basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	3 Qtrs
Basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$0.19	USD	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	365.60M	shares	1 Quarter
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	365.60M	shares	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	365.60M	shares	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	365.60M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-20.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$222.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$231.30M	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$12.60M	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-7.00M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$18.70M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$20.20M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$43.80M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$102.50M	USD	3 Qtrs
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	$16.00M	USD	3 Qtrs
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-42.70M	USD	3 Qtrs
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$83.40M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$2.80M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$3.50M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$347.80M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$167.10M	USD	3 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.70M	USD	3 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.30M	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$882.10M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$15.30M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.60M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-929.10M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.90M	USD	3 Qtrs
Proceeds from issuance of long-term debt (Note 8)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	3 Qtrs
Proceeds from issuance of long-term debt (Note 8)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$2.48B	USD	3 Qtrs
Proceeds from issuance of common stock (Note 1)	`ProceedsFromIssuanceOfCommonStock`	$1.66B	USD	3 Qtrs
Proceeds from issuance of common stock (Note 1)	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$3.56B	USD	3 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	-	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-500.00K	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.70M	USD	3 Qtrs
Other net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$844.00M	USD	3 Qtrs
Other net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-247.40M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$327.20M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$843.50M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.40M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$611.50M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$84.80M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$343.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$258.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$343.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$258.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$343.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$258.80M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$7.02B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.96B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.14B	USD	Point-in-time
Adoption of Accounting Standards Update 2016-16	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-300.00K	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-20.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$231.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$94.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-116.80M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$38.10M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$862.70M	USD	3 Qtrs
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-226.30M	USD	3 Qtrs
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$58.30M	USD	Point-in-time
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$58.30M	USD	3 Qtrs
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.66B	USD	3 Qtrs
Consideration to Lilly in connection with the Separation	`AdjustmentsToAdditionalPaidInCapitalSeparationPaymentToParent`	$4.19B	USD	3 Qtrs
Balance at end of period	`StockholdersEquity`	$7.02B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.96B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.14B	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-20.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$231.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$94.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-24.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$154.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$82.60M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$60.30M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.